A Study to Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors
Condition(s):Non-small Cell Lung Cancer MetastaticLast Updated:February 8, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung Cancer MetastaticLast Updated:February 8, 2018Unknown status
Condition(s):CancerLast Updated:May 30, 2017Completed
Condition(s):Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 PositiveLast Updated:January 9, 2019Terminated
Condition(s):CMLLast Updated:July 3, 2023Recruiting
Condition(s):Chronic Phase Chronic Myeloid Leukemia; Chronic Myeloid Leukemia, Chronic PhaseLast Updated:March 21, 2024Recruiting
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:January 10, 2019Unknown status
Condition(s):Patients Diagnosed as Chronic Meyloid LeukemiaLast Updated:February 22, 2022Unknown status
Condition(s):Liver NeoplasmsLast Updated:September 29, 2023Recruiting
Condition(s):Carcinoma, Adenoid CysticLast Updated:March 29, 2023Recruiting
Condition(s):Chronic Myeloid Leukemia, Chronic PhaseLast Updated:July 1, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.